Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 3,254 | 2,900 | 2,003 | 2,662 | 3,446 |
| Operating Income | -3,254 | -2,900 | -2,003 | -2,662 | -3,446 |
| Other Income | 159 | 164 | -1,105 | -1,359 | 33 |
| Pre-tax Income | -3,095 | -2,737 | -3,108 | -4,021 | -3,413 |
| Net Income Continuous | -3,095 | -2,737 | -3,108 | -4,021 | -3,413 |
| Net Income | $-3,095 | $-2,737 | $-3,108 | $-4,021 | $-3,413 |
| EPS Basic Total Ops | -0.31 | -0.28 | -1.20 | -1.55 | -1.32 |
| EPS Basic Continuous Ops | -0.31 | -0.28 | -1.20 | -1.55 | -1.32 |
| EPS Diluted Total Ops | -0.31 | -0.28 | -1.20 | -1.55 | -1.32 |
| EPS Diluted Continuous Ops | -0.31 | -0.28 | -1.20 | -1.55 | -1.32 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.28 | N/A | N/A | N/A |
| EBITDA(a) | $-3,248 | $-2,893 | $-1,996 | $-2,649 | $-3,442 |